Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
uniQure N.V. - Ordinary Shares
(NQ:
QURE
)
14.77
-0.83 (-5.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about uniQure N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Biotech Stock QURE Once Tagged ‘Failed Product’ — CEO Sold Shares Days Before Rally
↗
March 07, 2026
On Friday, the trading volume for uniQure increased from its 2 million shares to roughly 17 million.
Via
Stocktwits
UPCOMING DEADLINE: uniQure N.V. (QURE) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP
March 06, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Here are the top movers in Friday's session.
↗
March 06, 2026
Via
Chartmill
Deadline to Lead in Securities Fraud Lawsuit Against uniQure N.V. (QURE) is April 13, 2026 - Contact Kaplan Fox
March 06, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure (NASDAQ:QURE) Stock Plummets 40% Despite Earnings Beat on FDA Setback for AMT-130
↗
March 02, 2026
Via
Chartmill
Topics
Earnings
Deadline to Lead in Securities Fraud Lawsuit Against uniQure N.V. (QURE) is April 13, 2026 - Contact Kaplan Fox
March 06, 2026
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
March 06, 2026
From
Schall Law
Via
GlobeNewswire
Kaplan Fox Encourages Investors of uniQure N.V. (QURE) to Contact the Firm Before Lead Plaintiff Deadline on April 13, 2026
March 05, 2026
NEW YORK, NY - March 5, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf...
Via
TheNewswire.com
Topics
Lawsuit
Kaplan Fox Encourages Investors of uniQure N.V. (QURE) to Contact the Firm Before Lead Plaintiff Deadline on April 13, 2026
March 05, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
uniQure N.V. (QURE) Class Action Lawsuit Seeks Recovery for Investors; April 13, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
March 05, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Class Action Lawsuit Seeks Recovery for Investors; April 13, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
March 05, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline
March 05, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
March 04, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
March 04, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
March 04, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
March 03, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Kaplan Fox Alerts Investors of uniQure N.V. (QURE) to a Securities Class Action Deadline on April 13, 2026
March 03, 2026
NEW YORK, NY - March 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf...
Via
TheNewswire.com
Topics
Lawsuit
Kaplan Fox Alerts Investors of uniQure N.V. (QURE) to a Securities Class Action Deadline on April 13, 2026
March 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
March 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
March 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
March 03, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
March 03, 2026
From
Schall Law
Via
GlobeNewswire
These Analysts Cut Their Forecasts On uniQure Following Q4 Results
↗
March 03, 2026
uniQure (NASDAQ:QURE) reported positive Q4 results, but FDA advised against using data for market application of AMT-130. Stock down 13.3%.
Via
Benzinga
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
March 03, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Iran, Dip-Buyers & a Rare Buffett Stumble: Wall Street Shakes Off Its Worst Fears
↗
March 03, 2026
Via
Chartmill
Monday's session: top gainers and losers
↗
March 02, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
March 02, 2026
Via
Chartmill
uniQure (QURE) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
uniQure (QURE) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Get insights into the top gainers and losers of Monday's pre-market session.
↗
March 02, 2026
Via
Chartmill
Why Did QURE Stock Almost Halve Pre-Market Today?
↗
March 02, 2026
uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130.
Via
Stocktwits
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
